Allogene Therapeutics Inc (ALLO)

Other Income/Expenses (Net)

$14.82M

TTM · Period ending: · USD

ALLO logo

ALLO Other Income/Expenses (Net)

Latest reported$14.82M
ALLO TTM Other Income/Expenses (Net) (-$18.78M → $14.82M)
High-resolution chart · PNG

ALLO other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Allogene Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
14,823,000
16,456,000
18,429,000
15,829,000
17,809,000
17,006,000
16,052,000
10,975,000
6,203,000
2,438,000
-2,942,000
2,668,000
1,300,000
1,799,000
2,817,000
315,000
458,000
-1,256,000
-1,212,000
555,000
2,914,000
5,005,000
8,022,000
10,620,000
13,086,000
15,461,000
17,083,000
16,113,000
-9,506,000
-13,955,000
-18,780,000
-21,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.